Kanabo Group PLC Investor Updates
11 Mars 2022 - 12:23PM
RNS Non-Regulatory
TIDMKNB
Kanabo Group PLC
11 March 2022
Kanabo Group Plc
("Kanabo" or the "Company")
Investor Updates
Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis
Company focussing on the development and distribution of
cannabis-derived products for medical patients and wellness CBD
consumers, has posted their latest investor newsletter and investor
presentation to their website.
The latest Company presentation can be viewed here;
https://www.kanabogroup.com/wp-content/uploads/2022/03/Kanabo_GP_V01_230222.pdf
The Company has also posted a recent webinar with Vox Markets
where Kanabo CEO, Avihu Tamir and GP Service CEO, Atul Devani
discuss the GP Services acquisition. The webinar can be viewed
here;
Watch the Kanabo webinar hosted by Vox Markets - Vox Markets
The latest Kanabo Investor Newsletter discussing the significant
progress made over recent months can be viewed here;
https://www.kanabogroup.com/press/foreword-from-the-ceo-march-11-2002/
For further information, please visit
http://www.kanabogroup.com/ or contact the following:
Kanabo Group Plc
Avihu Tamir, CEO Via Vox Markets
Peterhouse Capital Ltd
Eran Zucker (Financial Adviser) Tel: +44 (0)20 7469
0930
Lucy Williams / Charles Goodfellow Tel: +44 (0)20 7469
(Corporate Broker) 0930
Vox Markets (Investor Relations)
Kat Perez KanaboGroup@voxmarkets.co.uk
About Kanabo Group Plc
Kanabo Group Plc is creating a new standard in the medical
cannabis industry to improve the well-being of millions of people
around the world by providing a better alternative to the smoking
of medicinal cannabis flowers. Kanabo, which was the first
medicinal cannabis company to IPO on London Stock Exchange, has a
focus on the distribution of cannabis-derived products for medical
patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality
cannabis extract formulas, innovative medical-grade vaporizers, and
various non-smoking consumption solutions. Kanabo sells a range of
medical cannabis products and wellness CBD products in the Primary
Markets, including its VapePod, which delivers a metered dose with
every inhalation.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABKDBBDBKDBND
(END) Dow Jones Newswires
March 11, 2022 06:23 ET (11:23 GMT)
Kanabo (LSE:KNB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Kanabo (LSE:KNB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024